Idiopathic Inflammatory Myopathies (IIMs)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Inflammatory Myopathies (IIMs) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Inflammatory Myopathies (IIMs) trials you may qualify forThis study aims to explore the clinical characteristics and mechanism of Deucravacitinib in the treatment of idiopathic inflammatory myopathies.Detailed Descrip…
The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan-DV) is safe and capable of inducing an…
A Basket Trial of Refractory Rheumatoid Arthritis (RA), Sjögren's Disease (SjD), Idiopathic Inflammatory Myopathies (IIMs) and Systemic Sclerosis (SSc) subjects…
This exploratory, single-arm, open-label study will evaluate the safety and preliminary efficacy of YTS109 cell therapy in pediatric patients with relapsed/refr…
1. To assess changes in impedance parameters in Idiopathic Inflammatory Myopathies (IIMs). 2. To assess whether EIM parameters are reflective of disease severit…